ORLANDO, Fla. (AP) - Marlon Byrd's steroids suspension two years ago didn't stop the Philadelphia Phillies from giving the outfielder a big contract.
Phillies general manager Ruben Amaro Jr. says ''unfortunately, it's part of the game and, hopefully, it's getting itself eliminated.''
At the time of his suspension, Byrd said he mistakenly used medication for a recurrence of a condition that earlier required surgery. He says he did not use it for performance enhancement.
Byrd's agreement calls for $8 million in each of the next two seasons and includes an $8 million team option for 2016. The option would become guaranteed if he has 1,100 at-bats in the next two seasons, including at least 550 in 2015, or 600 at-bats in 2015.
Advertisement

Top MLB Public Bets

Advertisement

MLB Top Stories

Thumbnail Jays, Bautista could be close to deal Could the Blue Jays be nearing a new deal with slugger Jose Bautista?
Thumbnail Red Sox favored to win AL Pennant The Boston Red Sox are favored to win the 2017 American League Pennant, while the defending champs have the next-best odds.
Thumbnail Updated 2017 NL Pennant Odds The Chicago Cubs remain favored to win the 2017 National League Pennant at 9/5, but which team is listed second?
Thumbnail Cubs remain World Series Favorites The Cubs remain favored to win the 2017 World Series while the Red Sox have the next-best odds according to oddsmakers.
Thumbnail Dodgers officially re-sign Jansen The Dodgers have officially re-signed Kenley Jansen to a five-year, $80 million contract.

MLB Team Pages